Vynleads (VYND) Debt to Equity (2020 - 2021)
Vynleads (VYND) reported Debt to Equity of -$0.02 for Q1 2021, up 10.92% on a QoQ basis from -$0.03 in Q4 2020.
Vynleads (VYND) has 2 years of Debt to Equity data on file, last reported at -$0.02 in Q1 2021.
- Quarterly Debt to Equity changed N/A year-over-year to -$0.02 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$0.02 (changed N/A YoY) and the FY2020 annual result came in at -$0.03, changed N/A from the prior year.
- Debt to Equity improved to -$0.02 in Q1 2021 per VYND's latest filing, from -$0.03 in the prior quarter.
- Across five years, Debt to Equity topped out at -$0.02 in Q1 2021 and bottomed at -$0.03 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 1.26 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.46 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.37 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Vynleads | - | - | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -0.02 |
| Dec 31, 2020 | -0.03 |